Results 71 to 80 of about 542 (130)

EHA2024 Hybrid Congress

open access: yes
HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

Podiatric Skin and Nail Involvement and Biomechanical Pathology in Renal Transplant Recipients: Assessment of the Foot as a Contributing Factor to Their Health. [PDF]

open access: yesHealthcare (Basel), 2023
González-Martín C   +5 more
europepmc   +1 more source

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia. [PDF]

open access: yesHaematologica, 2023
Kayser S   +31 more
europepmc   +1 more source

IgG4-Related Disease With Lung and Kidney Involvement: A Case Report. [PDF]

open access: yesCureus
Sá Lima A   +3 more
europepmc   +1 more source

Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023. [PDF]

open access: yesEuro Surveill, 2023
Gouveia C   +10 more
europepmc   +1 more source

Correction to: Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use. [PDF]

open access: yesPneumonia (Nathan)
Gomes-Silva J   +7 more
europepmc   +1 more source

Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study. [PDF]

open access: yesJ Clin Oncol
Montesinos P   +51 more
europepmc   +1 more source

Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database. [PDF]

open access: yesEye (Lond)
Zarranz-Ventura J   +8 more
europepmc   +1 more source

Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease. [PDF]

open access: yesInt J Mol Sci, 2023
Gené M   +15 more
europepmc   +1 more source

Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs. [PDF]

open access: yesAnn Hematol
Stuckey R   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy